{"id":25254,"date":"2025-05-08T08:39:21","date_gmt":"2025-05-08T06:39:21","guid":{"rendered":"https:\/\/ibsal.es\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/"},"modified":"2026-08-04T13:21:08","modified_gmt":"2026-08-04T11:21:08","slug":"michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3","status":"publish","type":"tribe_events","link":"https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/","title":{"rendered":"Michael J. Fox Foundation for Parkinson&#8217;s Research. Preclinical Therapeutics Pipeline Program 2025-3"},"content":{"rendered":"<h3 style=\"color: #003c8c\">Features<\/h3>\n<p>Through the call for proposals <a href=\"https:\/\/www.michaeljfox.org\/grant\/parkinsons-disease-therapeutics-pipeline-program\"><strong>Pre-clinical Therapeutics Pipeline Program 2025-3<\/strong><\/a> , the development of therapies with clear potential to prevent, halt, or slow the progression of <span style=\"color: #ff0000\"><strong>Parkinson\u2019s disease<\/strong><\/span> or to reduce the burden of daily symptoms.<\/p>\n<p>Specifically, through the &#8220;<strong><em>Pre-<\/em><em>Clinical<\/em><\/strong>&#8221; track will fund the identification, validation, and\/or development of new pharmacological and non-pharmacological interventions through preclinical development, from early detection to characterization and preclinical testing.<\/p>\n<p>Funding for projects will depend on their novelty, development status, and priority.<\/p>\n<ul>\n<li style=\"list-style-type: none\">\n<\/ul>\n<h3 style=\"color: #003c8c\">Requirements:<\/h3>\n<p>Applicants must be basic or clinical researchers affiliated with:<\/p>\n<ul>\n<li class=\"first\">Biotechnology\/pharmaceutical companies or other public or private for-profit organizations.<\/li>\n<li class=\"last\">Nonprofit organizations, whether public or private, such as universities, hospitals, or research centers.<\/li>\n<\/ul>\n<p>*Only applications from industry and from partnerships between academia and industry will be accepted.<\/p>\n<h3 style=\"color: #003c8c\">How to apply<\/h3>\n<p>Applications must be submitted through the <a href=\"https:\/\/grants.michaeljfox.org\/s_Login.jsp\"><strong>application portal<\/strong><\/a> and attaching the following documentation: <\/p>\n<ul>\n<li class=\"first\"><a class=\"external document\" href=\"https:\/\/www.michaeljfox.org\/sites\/default\/files\/media\/document\/Biosample%20Request%20Form%20-%20Pre-proposal.docx\" target=\"_blank\" rel=\"document noopener\">Biosample Request Form<\/a>.<\/li>\n<li class=\"last\"><a class=\"external document\" href=\"https:\/\/www.michaeljfox.org\/sites\/default\/files\/media\/document\/Pre-Clinical%20PD%20TPP%20Pre-Proposal%20Template.docx\" target=\"_blank\" rel=\"document noopener\">Preclinical application template<\/a>.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3 style=\"color: #003c8c\">Submission deadline.<\/h3>\n<p>The application process consists of two phases, with three deadlines set for the review of proposals in 2025:<\/p>\n<ol>\n<li class=\"first\">January 12, 2025<\/li>\n<li>March 27, 2025<\/li>\n<li class=\"last\"><span style=\"color: #ff0000\"><strong>Applications submitted by June 5, 2025, will be processed in August 2025.<\/strong><\/span><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Features Through the call for proposals Pre-clinical Therapeutics Pipeline Program 2025-3 , the development of therapies with clear potential to prevent, halt, or slow the progression of Parkinson\u2019s disease or [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"template":"","meta":{"_acf_changed":false,"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"_tribe_events_status":"","_tribe_events_status_reason":"","_tribe_events_is_hybrid":"","_tribe_events_is_virtual":"","_tribe_events_virtual_video_source":"","_tribe_events_virtual_embed_video":"","_tribe_events_virtual_linked_button_text":"","_tribe_events_virtual_linked_button":"","_tribe_events_virtual_show_embed_at":"","_tribe_events_virtual_show_embed_to":[],"_tribe_events_virtual_show_on_event":"","_tribe_events_virtual_show_on_views":"","_tribe_events_virtual_url":"","footnotes":"","_members_access_role":[],"_members_access_error":"","_tec_slr_enabled":"","_tec_slr_layout":""},"tags":[],"tribe_events_cat":[256],"class_list":["post-25254","tribe_events","type-tribe_events","status-publish","hentry","tribe_events_cat-calls-for-research","cat_calls-for-research"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.12 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Michael J. Fox Foundation for Parkinson&#039;s Research. Preclinical Therapeutics Pipeline Program 2025-3 | IBSAL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Michael J. Fox Foundation for Parkinson&#039;s Research. Preclinical Therapeutics Pipeline Program 2025-3\" \/>\n<meta property=\"og:description\" content=\"Features Through the call for proposals Pre-clinical Therapeutics Pipeline Program 2025-3 , the development of therapies with clear potential to prevent, halt, or slow the progression of Parkinson\u2019s disease or [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/\" \/>\n<meta property=\"og:site_name\" content=\"IBSAL\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-04T11:21:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibsal.es\/wp-content\/uploads\/2024\/10\/Snippet.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\\\/\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\\\/\",\"name\":\"Michael J. Fox Foundation for Parkinson's Research. Preclinical Therapeutics Pipeline Program 2025-3 | IBSAL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\"},\"datePublished\":\"2025-05-08T06:39:21+00:00\",\"dateModified\":\"2026-08-04T11:21:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibsal.es\\\/en\\\/institute-of-biomedical-research-of-salamanca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/ibsal.es\\\/en\\\/eventss\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Michael J. Fox Foundation for Parkinson&#8217;s Research. Preclinical Therapeutics Pipeline Program 2025-3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/\",\"name\":\"IBSAL\",\"description\":\"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n\",\"alternateName\":\"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibsal.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Michael J. Fox Foundation for Parkinson's Research. Preclinical Therapeutics Pipeline Program 2025-3 | IBSAL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/","og_locale":"en_US","og_type":"article","og_title":"Michael J. Fox Foundation for Parkinson's Research. Preclinical Therapeutics Pipeline Program 2025-3","og_description":"Features Through the call for proposals Pre-clinical Therapeutics Pipeline Program 2025-3 , the development of therapies with clear potential to prevent, halt, or slow the progression of Parkinson\u2019s disease or [&hellip;]","og_url":"https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/","og_site_name":"IBSAL","article_modified_time":"2026-08-04T11:21:08+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/ibsal.es\/wp-content\/uploads\/2024\/10\/Snippet.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/","url":"https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/","name":"Michael J. Fox Foundation for Parkinson's Research. Preclinical Therapeutics Pipeline Program 2025-3 | IBSAL","isPartOf":{"@id":"https:\/\/ibsal.es\/en\/#website"},"datePublished":"2025-05-08T06:39:21+00:00","dateModified":"2026-08-04T11:21:08+00:00","breadcrumb":{"@id":"https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibsal.es\/en\/evento\/michael-j-fox-foundation-for-parkinsons-research-preclinical-therapeutics-pipeline-program-2025-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibsal.es\/en\/institute-of-biomedical-research-of-salamanca\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/ibsal.es\/en\/eventss\/"},{"@type":"ListItem","position":3,"name":"Michael J. Fox Foundation for Parkinson&#8217;s Research. Preclinical Therapeutics Pipeline Program 2025-3"}]},{"@type":"WebSite","@id":"https:\/\/ibsal.es\/en\/#website","url":"https:\/\/ibsal.es\/en\/","name":"IBSAL","description":"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n","alternateName":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibsal.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"ticketed":false,"_links":{"self":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events\/25254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/users\/16"}],"version-history":[{"count":1,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events\/25254\/revisions"}],"predecessor-version":[{"id":25255,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events\/25254\/revisions\/25255"}],"wp:attachment":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/media?parent=25254"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tags?post=25254"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events_cat?post=25254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}